3a ), although it did not reach statistical significance in the daytime (Fig. 3b ).
← all excerpts
Increased fibroblast growth factor-21 in chronic kidney disease is a trade-off between survival benefit and blood pressure dysregulation.
1
—
—
3a ), although it did not reach statistical significance in the daytime (Fig. 3b ).